171 related articles for article (PubMed ID: 35649428)
1. Testing for Lupus Anticoagulants.
Moore GW
Semin Thromb Hemost; 2022 Sep; 48(6):643-660. PubMed ID: 35649428
[TBL] [Abstract][Full Text] [Related]
2. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
[TBL] [Abstract][Full Text] [Related]
3. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG
Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489
[TBL] [Abstract][Full Text] [Related]
4. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
Moore GW
Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
[TBL] [Abstract][Full Text] [Related]
5. Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).
Moore GW
Methods Mol Biol; 2023; 2663():275-288. PubMed ID: 37204717
[TBL] [Abstract][Full Text] [Related]
6. Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test.
Moore GW
Methods Mol Biol; 2023; 2663():263-274. PubMed ID: 37204716
[TBL] [Abstract][Full Text] [Related]
7. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
8. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
Galli M; Finazzi G; Bevers EM; Barbui T
Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
[TBL] [Abstract][Full Text] [Related]
9. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
[TBL] [Abstract][Full Text] [Related]
10. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
Moore GW; Foxton E; Platton S; Yartey N; White D; MacDonald SG
J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725
[TBL] [Abstract][Full Text] [Related]
11. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
Moore GW; Peyrafitte M; Dunois C; Amiral J
Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
[TBL] [Abstract][Full Text] [Related]
12. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
[TBL] [Abstract][Full Text] [Related]
13. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
Ząbczyk M; Kopytek M; Natorska J; Undas A
Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
[TBL] [Abstract][Full Text] [Related]
14. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Moore GW; Jones PO; Platton S; Hussain N; White D; Thomas W; Rigano J; Pouplard C; Gray E; Devreese KMJ
J Thromb Haemost; 2021 Dec; 19(12):3177-3192. PubMed ID: 34192404
[TBL] [Abstract][Full Text] [Related]
15. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
17. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
Court EL
Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
[TBL] [Abstract][Full Text] [Related]
18. Current Controversies in Lupus Anticoagulant Detection.
Moore GW
Antibodies (Basel); 2016 Dec; 5(4):. PubMed ID: 31558003
[TBL] [Abstract][Full Text] [Related]
19. Practical Considerations and Testing Nuances for the Detection of Lupus Anticoagulant: Do Low Phospholipid Screen Results, Assay Type, and Test Ratio Matter?
Asakrah S; Davis R; Bhargava P
Am J Clin Pathol; 2021 Nov; 156(6):1073-1082. PubMed ID: 34075395
[TBL] [Abstract][Full Text] [Related]
20. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
